Clinical Trials

Data supports Boston Scientific Watchman FLX in stroke reduction

Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

iPerf enrolls first patient in study of dual-flow femoral artery cannula

iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

Providence Medical enrols first patients in CORUS-LX system trial

Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

Senseonics reports sustained year-long CGM implant outcomes

Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

Arsenal Medical announces first patient treated with ResQFoam

Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

TECLens begins first-in-human trial for qCXL vision correction technology

TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

Kandu trial highlights positive outcomes with IpsiHand BCI system

Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy. The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...

CorTec announces successful second human implantation of its BCI system

CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...
123...58Page 2 of 58

Latest articles